Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Research Study Investigating How a New Medicine NNC0113-5840 Works in People With Overweight or Obesity
Sponsor: Novo Nordisk A/S
Summary
The purpose of this clinical study is to find out if NNC0113-5840 is safe for treating people with excess body weight. There are 2 study treatments in this study, participants will get either NNC0113-5840 (the product being tested) or Placebo (treatment that has no active medicine in it), Which treatment participants get is decided by chance.
Official title: A First in Human Dose Study Investigating the Safety, Tolerability and Pharmacokinetics of Single Ascending Doses of NNC0113-5840 in Participants With Overweight or Obesity
Key Details
Gender
All
Age Range
18 Years - 55 Years
Study Type
INTERVENTIONAL
Enrollment
48
Start Date
2026-05-01
Completion Date
2027-01-31
Last Updated
2026-09-09
Healthy Volunteers
No
Conditions
Interventions
NNC0113-5840
NNC0113-5840 will be administered subcutaneously using needle and syringe in a lifted fold of the abdominal skin.
Placebo
Placebo matched to NNC0113-5840 will be administered subcutaneously using needle and syringe in a lifted fold of the abdominal skin.
Locations (2)
PAREXEL Glendale/LA EPCU
Glendale, California, United States
PAREXEL Intl - EPCU-Baltimore
Baltimore, Maryland, United States